IL161164A0 - Preparation of levofloxacin and forms thereof - Google Patents
Preparation of levofloxacin and forms thereofInfo
- Publication number
- IL161164A0 IL161164A0 IL16116402A IL16116402A IL161164A0 IL 161164 A0 IL161164 A0 IL 161164A0 IL 16116402 A IL16116402 A IL 16116402A IL 16116402 A IL16116402 A IL 16116402A IL 161164 A0 IL161164 A0 IL 161164A0
- Authority
- IL
- Israel
- Prior art keywords
- levofloxacin
- forms
- preparation
- methyl
- benzoxazine
- Prior art date
Links
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 title abstract 5
- 229960003376 levofloxacin Drugs 0.000 title abstract 5
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 abstract 1
- NVKWWNNJFKZNJO-YFKPBYRVSA-N Ofloxacin impurity a Chemical compound N1([C@@H](C)CO2)C=C(C(O)=O)C(=O)C3=C1C2=C(F)C(F)=C3 NVKWWNNJFKZNJO-YFKPBYRVSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002798 polar solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32695801P | 2001-10-03 | 2001-10-03 | |
US33431601P | 2001-11-29 | 2001-11-29 | |
US35493902P | 2002-02-11 | 2002-02-11 | |
PCT/US2002/031850 WO2003028664A2 (en) | 2001-10-03 | 2002-10-03 | Preparation of levofloxacin and forms thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL161164A0 true IL161164A0 (en) | 2004-08-31 |
Family
ID=27406493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16116402A IL161164A0 (en) | 2001-10-03 | 2002-10-03 | Preparation of levofloxacin and forms thereof |
Country Status (11)
Country | Link |
---|---|
US (2) | US7629458B2 (xx) |
EP (3) | EP1451194B2 (xx) |
JP (5) | JP2005504818A (xx) |
AT (1) | ATE341553T1 (xx) |
AU (2) | AU2002341991A1 (xx) |
CA (1) | CA2462023A1 (xx) |
DE (1) | DE60215213T3 (xx) |
ES (1) | ES2272781T5 (xx) |
IL (1) | IL161164A0 (xx) |
PT (1) | PT1451194E (xx) |
WO (2) | WO2003028664A2 (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7425628B2 (en) | 2001-10-03 | 2008-09-16 | Teva Pharmaceutical Industries Ltd. | Methods for the purification of levofloxacin |
EP1451194B2 (en) * | 2001-10-03 | 2009-12-16 | Teva Pharmaceutical Industries Ltd. | Preparation of levofloxacin hemihydrate |
CN1596256A (zh) * | 2001-11-29 | 2005-03-16 | 特瓦制药工业有限公司 | 左氧氟沙星的纯化方法 |
CN100412075C (zh) * | 2004-06-22 | 2008-08-20 | 浙江医药股份有限公司新昌制药厂 | 左旋氧氟沙星和氧氟沙星的制备方法 |
EP1797101A4 (en) * | 2004-09-17 | 2009-11-11 | Matrix Lab Ltd | IMPROVED PROCESS FOR THE PREPARATION OF LEVOFLOXACIN HEMIHYDRATE |
FR2875807B1 (fr) * | 2004-09-30 | 2006-11-17 | Servier Lab | Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
US20070244318A1 (en) * | 2004-11-08 | 2007-10-18 | Rao Davuluri R | Process for the Preparation of Levofloxacin Hemihydrate |
JP2006273718A (ja) * | 2005-03-28 | 2006-10-12 | Shiono Chemical Co Ltd | レボフロキサシン・1/2水和物の製法 |
US7902227B2 (en) | 2007-07-27 | 2011-03-08 | Janssen Pharmaceutica Nv. | C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents |
US7964723B2 (en) | 2008-08-02 | 2011-06-21 | Apeloa-Kangyu | And practical process for exclusively producing (S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido-[1,2,3,de][1,4]benzoxazine-6-carboxylic acid hemihydrate |
CN102146087B (zh) * | 2010-02-10 | 2015-08-12 | 广东东阳光药业有限公司 | 一种制备高纯度左氧氟沙星半水合物的方法 |
MX349603B (es) * | 2010-02-25 | 2017-08-03 | Santen Pharmaceutical Co Ltd | Solucion oftalmica para tratar infeccion ocular que comprende levofloxacina o sal de la misma o solvato de la misma, metodo para tratar infeccion ocular, levofloxacina o sal de la misma o solvato de la misma, y uso de la misma. |
CN102558197A (zh) * | 2012-01-11 | 2012-07-11 | 浙江医药股份有限公司新昌制药厂 | 左氧氟沙星-n-氧化物的制备方法 |
CN102850377B (zh) * | 2012-09-04 | 2014-05-21 | 苏州弘森药业有限公司 | 一种盐酸左氧氟沙星的制备方法 |
KR102381295B1 (ko) | 2013-11-15 | 2022-03-31 | 아케비아 테라퓨틱스 인코포레이티드 | {[5-(3-클로로페닐)-3-하이드록시피리딘-2-카보닐]아미노}아세트산의 고체형, 이의 조성물 및 용도 |
CN114507242B (zh) * | 2022-01-26 | 2023-05-19 | 上虞京新药业有限公司 | 高光学纯度左氧氟沙星的制备方法 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5746986A (en) | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
DK170473B1 (da) * | 1985-06-20 | 1995-09-11 | Daiichi Seiyaku Co | S(-)-pyridobenzoxazinforbindelser |
JPH0747592B2 (ja) | 1985-06-20 | 1995-05-24 | 第一製薬株式会社 | ピリドベンゾオキサジン誘導体 |
DE3543513A1 (de) | 1985-12-10 | 1987-06-11 | Bayer Ag | Enantiomerenreine 1,8-verbrueckte 4-chinolon-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel und ihre verwendung zur herstellung von arzneimitteln |
US5237060A (en) * | 1985-12-10 | 1993-08-17 | Bayer Aktiengesellschaft | Process of preparing enantiomerically pure 1,8-bridged 4-quinolone-3-carboxylic acids |
JPS62198685A (ja) | 1986-02-26 | 1987-09-02 | Kyorin Pharmaceut Co Ltd | キノロンカルボン酸誘導体及びその製造方法 |
US4777253A (en) * | 1986-04-25 | 1988-10-11 | Abbott Laboratories | Process for preparation of racemate and optically active ofloxacin and related derivatives |
AU4376589A (en) | 1988-11-07 | 1990-05-10 | Gist-Brocades N.V. | Optically active benzoxazines and benzothiazines |
JP3105572B2 (ja) | 1990-03-01 | 2000-11-06 | 第一製薬株式会社 | 水和物の選択的製法 |
TW208013B (xx) * | 1990-03-01 | 1993-06-21 | Daiichi Co Ltd | |
KR920003605B1 (ko) | 1990-03-27 | 1992-05-04 | 한국과학기술연구원 | 피페라지닐 퀴놀론 유도체의 제조방법 |
DE4019023A1 (de) | 1990-06-14 | 1991-12-19 | Bayer Ag | Verfahren zur herstellung von chinolincarbonsaeuren |
DE4210941A1 (de) | 1992-04-02 | 1993-10-07 | Bayer Ag | Neue 9-Fluor-7.oxo-7H-pyrido[1,2,3-d,e][1,4]benzoxacin-6-carbonsäuren und -ester |
JPH0632776A (ja) | 1992-07-14 | 1994-02-08 | Mitsubishi Rayon Co Ltd | N−(D−α−メチル−β−メルカプトプロピオニル)−L−プロリンの酸化防止法 |
ES2055656B1 (es) | 1992-10-07 | 1995-11-16 | Etilo Derivados | Procedimiento para la obtencion de benzoxazinas utiles para sintesis de ofloxacina, levofloxacina y derivados. |
US5521310A (en) * | 1992-10-07 | 1996-05-28 | Derivados Del Etilo, S.A. | Process to obtain benzoxazines to be used for the synthesis of ofloxazine, levofloxazine and derivatives |
KR0125115B1 (ko) † | 1994-03-22 | 1997-12-05 | 김은영 | (-)피페라진 벤즈옥사진 유도체의 제조방법 |
DE19729879C2 (de) | 1997-07-11 | 1999-07-08 | Mann Gerhard Chem Pharm Fab | Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin |
JPH11349589A (ja) | 1997-12-24 | 1999-12-21 | Sankyo Co Ltd | 縮環キノリンカルボン酸誘導体 |
KR100309871B1 (ko) * | 1999-02-24 | 2001-10-29 | 윤종용 | (-)피리도벤즈옥사진 카르복실산 유도체의 제조방법 |
DE19826050A1 (de) * | 1998-06-12 | 1999-12-16 | Bayer Ag | Verfahren zur Herstellung von Chinolon- und Naphthyridoncarbonsäuren und deren Ester |
ES2424813T3 (es) | 1999-09-08 | 2013-10-08 | Daiichi Sankyo Company, Limited | Productos intermedios y su uso para la producción de derivado de benzoxazina |
US7425628B2 (en) * | 2001-10-03 | 2008-09-16 | Teva Pharmaceutical Industries Ltd. | Methods for the purification of levofloxacin |
EP1451194B2 (en) | 2001-10-03 | 2009-12-16 | Teva Pharmaceutical Industries Ltd. | Preparation of levofloxacin hemihydrate |
CN1596256A (zh) | 2001-11-29 | 2005-03-16 | 特瓦制药工业有限公司 | 左氧氟沙星的纯化方法 |
US20040152701A1 (en) * | 2002-12-02 | 2004-08-05 | Dr. Reddy's Laboratories Limited | Novel anhydrous crystalline form of Levofloxacin and process for preparation there of |
WO2004055025A1 (en) | 2002-12-16 | 2004-07-01 | Ranbaxy Laboratories Limited | Pure levofloxacin hemihydrate and processes for preparation thereof |
KR100704641B1 (ko) | 2004-07-21 | 2007-04-06 | 주식회사유한양행 | 고순도의 레보플록사신 제조방법 |
EP1797101A4 (en) * | 2004-09-17 | 2009-11-11 | Matrix Lab Ltd | IMPROVED PROCESS FOR THE PREPARATION OF LEVOFLOXACIN HEMIHYDRATE |
WO2008077643A1 (en) | 2006-12-22 | 2008-07-03 | Farmaprojects, S.A. | Process for the preparation of an antibacterial quinolone compound |
-
2002
- 2002-10-03 EP EP02776152A patent/EP1451194B2/en not_active Expired - Lifetime
- 2002-10-03 AU AU2002341991A patent/AU2002341991A1/en not_active Abandoned
- 2002-10-03 EP EP06020684A patent/EP1772457A3/en not_active Withdrawn
- 2002-10-03 IL IL16116402A patent/IL161164A0/xx unknown
- 2002-10-03 JP JP2003532000A patent/JP2005504818A/ja not_active Withdrawn
- 2002-10-03 WO PCT/US2002/031850 patent/WO2003028664A2/en active IP Right Grant
- 2002-10-03 AU AU2002341990A patent/AU2002341990A1/en not_active Abandoned
- 2002-10-03 EP EP08015768A patent/EP1992629A1/en not_active Withdrawn
- 2002-10-03 AT AT02776152T patent/ATE341553T1/de not_active IP Right Cessation
- 2002-10-03 CA CA002462023A patent/CA2462023A1/en not_active Abandoned
- 2002-10-03 DE DE60215213T patent/DE60215213T3/de not_active Expired - Lifetime
- 2002-10-03 ES ES02776152T patent/ES2272781T5/es not_active Expired - Lifetime
- 2002-10-03 US US10/263,192 patent/US7629458B2/en not_active Expired - Fee Related
- 2002-10-03 PT PT02776152T patent/PT1451194E/pt unknown
- 2002-10-03 WO PCT/US2002/031851 patent/WO2003028665A2/en not_active Application Discontinuation
-
2005
- 2005-05-26 US US11/137,348 patent/US20050222409A1/en not_active Abandoned
-
2006
- 2006-05-15 JP JP2006135884A patent/JP2006265261A/ja not_active Withdrawn
- 2006-11-17 JP JP2006311904A patent/JP2007131628A/ja active Pending
-
2007
- 2007-01-25 JP JP2007015655A patent/JP2007169288A/ja active Pending
-
2008
- 2008-04-02 JP JP2008096368A patent/JP2008273956A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2003028664A2 (en) | 2003-04-10 |
US7629458B2 (en) | 2009-12-08 |
EP1772457A2 (en) | 2007-04-11 |
EP1992629A1 (en) | 2008-11-19 |
WO2003028664A3 (en) | 2003-11-20 |
AU2002341990A1 (en) | 2003-04-14 |
JP2007131628A (ja) | 2007-05-31 |
JP2005504818A (ja) | 2005-02-17 |
US20030130507A1 (en) | 2003-07-10 |
DE60215213T2 (de) | 2007-08-30 |
DE60215213D1 (de) | 2006-11-16 |
EP1451194A2 (en) | 2004-09-01 |
PT1451194E (pt) | 2007-01-31 |
EP1772457A3 (en) | 2007-07-04 |
ATE341553T1 (de) | 2006-10-15 |
EP1451194B2 (en) | 2009-12-16 |
ES2272781T5 (es) | 2010-04-06 |
EP1451194A4 (en) | 2005-06-22 |
DE60215213T3 (de) | 2010-07-01 |
US20050222409A1 (en) | 2005-10-06 |
WO2003028665A2 (en) | 2003-04-10 |
JP2007169288A (ja) | 2007-07-05 |
JP2008273956A (ja) | 2008-11-13 |
WO2003028665A3 (en) | 2003-11-20 |
JP2006265261A (ja) | 2006-10-05 |
AU2002341991A1 (en) | 2003-04-14 |
CA2462023A1 (en) | 2003-04-10 |
EP1451194B1 (en) | 2006-10-04 |
ES2272781T3 (es) | 2007-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL161164A0 (en) | Preparation of levofloxacin and forms thereof | |
TWI265163B (en) | Novel pyrido[2,1-a]isoquinoline derivatives | |
DE69601345D1 (de) | Propiophenon-Derivate und Verfahren zur ihrer Herstellung | |
UA93043C2 (ru) | ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ ДЛЯ ПОЛУЧЕНИЯ ТРАНС-5-ХЛОР-2-МЕТИЛ-2,3,3А,12В-ТЕТРАГИДРО-1Н-ДИБЕНЗ[2,3:6,7]ОКСЕПИНО[4,5-с]ПИРОЛА | |
MX9603593A (es) | Derivados de quinazolina. | |
MXPA03012013A (es) | Derivados de 1-oxa-2,8-diaza-spiro[4,5]dec-2-eno sustituidos como medicamento para el tratamiento de dolor. | |
WO2005020894A3 (en) | Rifamycin analogs and uses thereof | |
FI894045A (fi) | Menetelmä terapeuttisesti aktiivisen 10-atsaspiro-9-fluori-2,3-dihydro-3-metyyli-7-okso-7H-pyrido/1,2,3-de//1,4/bentsoksatsiini-6-karboksyylihappojohdannaisen valmistamiseksi | |
CA2262566A1 (en) | Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect | |
WO2002085843A3 (en) | Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds | |
TW200626600A (en) | Octahydropyrrolo[3, 4-c]pyrrole derivatives | |
AU5314894A (en) | Novel derivatives of quinolonecarboxylic acid and naphthyridonecarboxylic acid | |
MY129173A (en) | Novel cyclopentene derivatives useful as antagonists of the motilin receptor | |
WO2004019879A3 (en) | Motilide compounds | |
WO1992017445A3 (en) | S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof | |
TW328954B (en) | Quinoxalines, a process for their preparation, and their use | |
ATE115580T1 (de) | Verfahren und zwischenprodukte zur herstellung von azabicyclo(2.2.2>octan-3-iminen. | |
IL125072A0 (en) | Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives their preparation and use | |
AU2003224115A1 (en) | A process for the preparation of clopidogrel | |
AU6890894A (en) | Aminobenzoic acid derivatives | |
AU5788594A (en) | Heterotricyclically substituted phenyl-cyclohexane- carboxylic acid derivatives | |
AU3259997A (en) | Ring-fused dihydropyranes, process for the preparation and use thereof | |
ATE73767T1 (de) | Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung. | |
PL345966A1 (en) | N-substituted azabicycloheptane derivatives, production and use thereof | |
WO2002051845A3 (en) | Triazolopyrimidines |